Teva Pharmaceuticals Will Pay $450M In False Claims Act Settlement To Resolve Kickback Allegations Relating To Copayments And Price Fixing
The United States Department of Justice announced on October 10, 2024 that Teva Pharmaceuticals USA Inc. (Teva USA) and Teva Neuroscience Inc. have agreed to pay $450 million to resolve two matters that allege Teva violated the Anti-Kickback Statute (AKS) and the False Claims Act (FCA). Teva, headqu[...]